Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Roche patents TLR antagonists

May 20, 2021

First-in-class small molecule PX-69 activates PLXDC2 to treat rheumatoid arthritis

May 20, 2021

T-cell modulation elicits long-term arthritis remission

May 19, 2021

Data presented from low-dose cohort of first-in-human trial FX-201

May 18, 2021

Interim phase I data for scAAV-2.5-IL1R as local gene therapy in OA of the knee

May 18, 2021

Astellas studies ASP-0367 in phase II/III for primary mitochondrial myopathy

May 14, 2021

Topline data from U.S. phase II IXPLORE study of vilobelimab in AAV

May 12, 2021

FDA grants IND approval for Zofin in the treatment of osteoarthritis

April 22, 2021

New phase II trial evaluates pyridostigmine with ondansetron in myasthenia gravis

April 15, 2021

Roche synthesizes new TLR antagonists

April 9, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...